Stay updated on Nivolumab Ipilimumab Local Consolidation Clinical Trial
Sign up to get notified when there's something new on the Nivolumab Ipilimumab Local Consolidation Clinical Trial page.

Latest updates to the Nivolumab Ipilimumab Local Consolidation Clinical Trial page
- Check4 days agoNo Change Detected
- Check11 days agoChange DetectedRevision updated to v3.4.3; the previous version v3.4.2 was removed.SummaryDifference0.0%

- Check19 days agoNo Change Detected
- Check33 days agoChange DetectedThe page revision label changed from v3.4.1 to v3.4.2.SummaryDifference0.0%

- Check40 days agoChange DetectedAdded Revision: v3.4.1 and removed Revision: v3.4.0.SummaryDifference0.0%

- Check47 days agoChange DetectedThe page now displays a glossary option and includes updated metadata labels such as 'Last Update Submitted that Met QC Criteria' with a revision bump to v3.4.0, and capitalization changes for 'No FEAR Act Data'. To avoid being alerted by small changes, set an alert condition by clicking below.SummaryDifference0.2%

- Check62 days agoChange DetectedThe page shows a revision update to v3.3.4 replacing the previous v3.3.3, with no substantive changes to the study details.SummaryDifference0.0%

- Check83 days agoChange DetectedRevision updated to v3.3.3 with new dates (2025-12-11, 2025-12-17, 2026-03-31) and addition of Texas locations. Older entries including HHS Vulnerability Disclosure, Texas Locations, and the prior revision (v3.3.2) were removed.SummaryDifference0.5%

Stay in the know with updates to Nivolumab Ipilimumab Local Consolidation Clinical Trial
Enter your email address, and we'll notify you when there's something new on the Nivolumab Ipilimumab Local Consolidation Clinical Trial page.